Acute Esophagitis and Late Lung Toxicity in Concurrent Chemoradiotherapy Trials in Patients with Locally Advanced Non–Small-Cell Lung Cancer: Analysis of the Radiation Therapy Oncology Group (RTOG) Database
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference36 articles.
1. Response, toxicity, failure patterns, and survival in five RTOG trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small cell carcinoma of the lung;Byhardt;Int J Radiat Oncol Biol Phys,1998
2. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer;Choy;J Clin Oncol,1998
3. Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: A multivariate analysis of 1076 RTOG patients;Werner-Wasik;Int J Radiat Oncol Biol Phys,1999
4. Patient-reported short-term and long-term physical and psychologic symptoms: results of the Continuous Hyperfractionated Accelerated Radiotherapy (CHART) randomized trial in non-small cell lung cancer;Bailey;J Clin Oncol,1998
5. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma;Bradley;Int J Radiat Oncol Biol Phys,2005
Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Factors associated with acute esophagitis during radiation therapy for lung cancer;Radiotherapy and Oncology;2024-08
2. Explainable deep learning-based survival prediction for non-small cell lung cancer patients undergoing radical radiotherapy;Radiotherapy and Oncology;2024-04
3. Herausforderungen in der multimodalen Therapie älterer Patient:innen mit Lungenkarzinomen;Die Onkologie;2024-01-02
4. Chest and thorax: Symptoms and toxicities;Palliative Radiation Oncology;2024
5. Kombination Radio(chemo)therapie beim Lungenkarzinom – Nebenwirkungsmanagement;best practice onkologie;2023-10-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3